Picture of TOWA PHARMACEUTICAL logo

4553 — TOWA PHARMACEUTICAL News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Towa Pharmaceutical -2022/23 parent results

May 15 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            124.00          123.30                                
                 (+0.6 pct)      (+6.9 pct)                              
  Operating          9.31           18.74                                
                 (-50.3 pct)     (-6.0 pct)                              
  Recurring          8.54           22.49                                
                 (-62.0 pct)     (+20.7 pct)                             
  Net                6.33           16.32                                
                 (-61.2 pct)     (+19.5 pct)                             
  EPS            128.60 yen      331.57 yen                              
  EPS Diluted                    324.22 yen                              
  Ann Div         60.00 yen       60.00 yen      60.00 yen               
  -Q2 Div         30.00 yen       27.00 yen      30.00 yen               
  -Q4 Div         30.00 yen       33.00 yen      30.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T

Recent news on TOWA PHARMACEUTICAL

See all news